Search results for: Value-Based Pricing
Filter search results
OHE at iHEA 2017: Presentations
8 August 2017
…Externally-Collected Vignettes from Office of Health Economics. Mikel Berdud gave a presentation on: Establishing a Fair Price for an Orphan Drug. Mikel discussed a way to set prices based…
Routine Funding in the UK NHS of Medicines Authorised Between 2011 and 2016 via the European Centralised Procedure
18 December 2017
This report analyses patient access in the UK to new medicines authorised via the centralised procedure between 2011 and 2016. The centralised procedure was created in 1995 to facilitate access…
Incorporating Quantitative Patient Preference Data into Healthcare Decision Making Processes: Is HTA Falling Behind?
4 April 2018
A recently published editorial by OHE’s David Mott considers whether quantitative patient preference data has a role to play in HTA decision making. A recently published editorial by OHE’s David…
Measuring UK Medicines Expenditure in the Context of the 2014-18 PPRS
29 August 2018
OHE Consulting produces a report on Measuring UK Medicines Expenditure in the Context of the 2014-18 PPRS. This OHE Consulting Report, published today, reviews “Measurement of Medicines Expenditure in the…
New Publications: Real-World Evidence for Coverage and Formulary Decisions
7 December 2018
…the optimal development and use of real-world evidence for drug coverage and formulary decisions. This paper summarises the authors’ reflections based on the discussions held at the Summit. For more…
The Faces of Regulation: Profit and Price Regulation of the UK Pharmaceutical Industry after the 1998 Competition Act
1 May 2006
This Briefing discusses, inter alia, the role of the Office of Fair Trading (OFT) in competition cases affecting the pharmaceutical industry. It does so in the context of a discussion…
Incorporating Life-cycle Price Modelling into Pharmaceutical Cost-effectiveness Evaluations
1 August 2015
Why might the launch price of a new drug be a poor indicator of future expenditure for a drug? Which are the factors that determine the future prices and market…
How Should the World Pay for a COVID-19 Vaccine?
1 July 2020
This year’s OHE lecture addresses the question: how should the world pay for a COVID-19 vaccine? Adrian Towse, Emeritus Director of OHE and Senior Research Fellow presents the challenges that…
Real-World Evidence: Current Best Practice for Reimbursement Decision-Making
15 May 2023
Share this: Download publication Sian Hodgson Amanda Cole Raoh-Fang Pwu Jason Chia-Hsun Hsieh In this report, we discuss best practices for RWE generation and the steps needed to enhance the…